Sucampo Pharma (NASDAQ: SCMP) announced the successful completion of the European Mutual Recognition Procedure (MRP) for AMITIZA (lubiprostone) for the ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE